Ecolab Life Sciences is launching its new Purolite AP+50 affinity chromatography resin at the Biotechnology Innovation Organization (BIO) International Convention, which is being held in Boston from June 16–19, 2025. The new resin, according to a June 16, 2025 press release (1), can optimize operations during the antibody manufacturing process.
Key Takeaways
- The Purolite AP+50 affinity chromatography resin has a 50-micron bead size that provides dynamic binding capacity of the AP resin platform and durability for monoclonal antibodies.
- The resin uses Ecolab’s patented Jetted resin bead manufacturing technology.
- Ecolab will be giving a technical presentation during the BIO event at the BPI Theatre on Tuesday, June 17 at 2:40 p.m.
The affinity chromatography resin has a 50-micron bead size that provides dynamic binding capacity of the AP resin platform and durability for monoclonal antibodies. It uses Ecolab’s patented Jetted resin bead manufacturing technology, which enables consistent and shorter lot-to-lot lead times.
“The ability to effectively improve process economics while maintaining purity is the gold standard of resin purification. As pharmaceutical and biotech companies seek to increase savings and improve business continuity, they are requiring innovative solutions to accelerate and de-risk manufacturing,” Meeta Gulyani, senior vice president and general manager, Ecolab Bioprocessing, said in the press release. “Our resins are designed to help customers improve their product development platforms and implement next-generation manufacturing processes as well as enhance dual sourcing strategies that can reduce costs and bolster supply chains.”
The new resin joins the company’s Purolite Resin toolbox for dealing with complex purification challenges. Purolite DurA Cycle A50, a protein A chromatography resin for large-scale purification processes, was launched at the 2024 BIO event.
“The launch of DurA Cycle chromatography resin underscores Ecolab’s 100-year heritage of innovation and ongoing investment in Purolite, reaffirming our commitment to the bioprocessing industry. This new resin enables biologic developers to increase manufacturing efficiencies, reduce their cost of goods, and accelerate the delivery of innovation to the clinic,” said Srini Paluri, senior vice-president and general manager at Purolite, in a June 3, 2024, company press release (2).